...
首页> 外文期刊>Neurotherapeutics >Intrathecal pumps
【24h】

Intrathecal pumps

机译:鞘内泵

获取原文
获取原文并翻译 | 示例
           

摘要

Direct neuroaxis drug delivery has expanded the physician’s armamentarium to provide treatment options to those who have failed more conservative interventions. Starting from Bier’s ‘cocainization of the spinal cord’ in 1898, direct nervous system pharmacy delivery has long been recognized as an effective means to treat pain. Intrathecal pump systems are now commonplace in the management of numerous pain states, as well as of neuromuscular sequelae of central nervous system injury. There has been much advancement in the physiologic and pharmacologic understanding of direct neuromodulation, providing a growing number of treatment options depending on the specific disease state. As well, surgical techniques and catheter systems have undergone refinements providing improved long-term safety and efficacy. We present a review of the historical evolution to current intrathecal therapies, as well as a dialog regarding patient selection, drug options, and side effects. Also, included is a discussion of surgical techniques, current delivery options and complications concerning pump placement.
机译:直接神经轴药物递送扩大了医生的军备库,为那些较保守的干预措施失败的人提供治疗选择。从比尔(Bier)于1898年“脊髓可卡因化”开始,直接神经系统药房的运送一直被认为是治疗疼痛的有效手段。鞘内泵系统现在在许多疼痛状态以及中枢神经系统损伤的神经肌肉后遗症的治疗中司空见惯。在直接神经调节的生理学和药理学理解方面已经取得了很大进步,根据特定疾病状态,提供了越来越多的治疗选择。同样,外科技术和导管系统已经进行了改进,从而提供了改善的长期安全性和有效性。我们对当前鞘内治疗的历史演变进行了回顾,并就患者选择,药物选择和副作用进行了对话。此外,还讨论了外科技术,当前的输送选择以及有关泵放置的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号